Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
IssuerBlackrock
ETF TickerBTEE(USD) LSE
ETF TickerBTEE.L(GBP) LSE

Holdings detail for MNMD

Stock NameMind Medicine Inc
TickerMNMD(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINCA60255C8850

Show aggregate MNMD holdings

News associated with MNMD

Blair William & Co. IL Takes $73,000 Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
Blair William & Co. IL acquired a new stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 12,500 shares of the company’s stock, valued at approximately $73,000. Several other large investors have also […] - 2025-08-14 05:02:58
MindMed Reports Strong Q2 2025 Results
Mind Medicine (MindMed)(NASDAQ:MNMD) reported Q2 2025 results on July 31, 2025. The company maintained strong enrollment momentum across all three pivotal phase 3 trials for MM120 ODT, confirmed a cash position of $237.9 million as of Q2 2025, sufficient to fund operations throug - 2025-08-11 05:37:30
1 Reason to Buy MindMed (MNMD)
Key PointsThe company must operate under strict regulations, as it is developing certain medicines based on psychedelic substances. - 2025-08-07 06:25:00
Mind Medicine (MindMed) (NASDAQ:MNMD) Earns Outperform Rating from Analysts at Oppenheimer
Oppenheimer assumed coverage on shares of Mind Medicine (MindMed) (NASDAQ:MNMD – Free Report) in a report released on Monday, MarketBeat.com reports. The brokerage issued an outperform rating and a $25.00 price objective on the stock. Other research analysts have also recently issued reports about the stock. Chardan Capital reissued a “buy” rating and set a […] - 2025-08-07 03:06:55
Mind Medicine (MindMed) (NASDAQ:MNMD) Given “Buy” Rating at Chardan Capital
Chardan Capital reissued their buy rating on shares of Mind Medicine (MindMed) (NASDAQ:MNMD – Free Report) in a research note released on Friday morning,Benzinga reports. Chardan Capital currently has a $20.00 price objective on the stock. Separately, Cantor Fitzgerald raised Mind Medicine (MindMed) to a “strong-buy” rating in a report on Tuesday, May 13th. Seven […] - 2025-08-04 02:48:46
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Recommendation of “Buy” from Analysts
Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) have been given an average recommendation of “Buy” by the nine ratings firms that are currently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The […] - 2025-07-29 02:14:49
Teacher Retirement System of Texas Sells 3,345 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
Teacher Retirement System of Texas decreased its stake in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 18.4% during the first quarter, HoldingsChannel reports. The firm owned 14,860 shares of the company’s stock after selling 3,345 shares during the quarter. Teacher Retirement System of Texas’ holdings in Mind Medicine (MindMed) were worth […] - 2025-07-22 04:12:51
Analysts Set Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Target Price at $25.50
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has been assigned a consensus rating of “Buy” from the eleven analysts that are presently covering the stock, MarketBeat reports. Eight investment analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. The average 1-year price […] - 2025-07-07 02:32:46
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Rating of “Buy” from Brokerages
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has been assigned an average rating of “Buy” from the eleven ratings firms that are covering the firm, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy recommendation and three have assigned a strong buy recommendation to the company. The average 12-month […] - 2025-06-09 02:34:47
Reviewing Mind Medicine (MindMed) (NASDAQ:MNMD) and PacificHealth Laboratories (OTCMKTS:PHLI)
Mind Medicine (MindMed) (NASDAQ:MNMD – Get Free Report) and PacificHealth Laboratories (OTCMKTS:PHLI – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, institutional ownership and risk. Analyst Recommendations This is a breakdown of […] - 2025-06-06 02:55:01
BNP Paribas Financial Markets Invests $74,000 in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
BNP Paribas Financial Markets purchased a new position in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) in the 4th quarter, Holdings Channel reports. The fund purchased 10,631 shares of the company’s stock, valued at approximately $74,000. Several other institutional investors have also modified their holdings of the company. Ameriprise Financial Inc. bought […] - 2025-06-02 04:44:55
Northern Trust Corp Has $4.77 Million Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
Northern Trust Corp raised its stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 12.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 684,836 shares of the company’s stock after purchasing an additional 76,559 shares during the period. […] - 2025-05-22 04:20:53
Raymond James Financial Inc. Acquires Shares of 16,004 Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
Raymond James Financial Inc. bought a new position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 16,004 shares of the company’s stock, valued at approximately $111,000. Several other institutional investors and hedge funds also recently bought and sold […] - 2025-05-14 04:22:48
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Bought by Wells Fargo & Company MN
Wells Fargo & Company MN raised its stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 61.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 39,974 shares of the company’s stock after purchasing an additional 15,269 shares during the period. Wells Fargo & Company MN’s […] - 2025-05-07 04:18:53
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Sold by Legal & General Group Plc
Legal & General Group Plc cut its holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 8.8% during the fourth quarter, HoldingsChannel reports. The fund owned 58,437 shares of the company’s stock after selling 5,639 shares during the period. Legal & General Group Plc’s holdings in Mind Medicine (MindMed) were worth $407,000 at […] - 2025-04-30 04:54:53
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives $25.11 Consensus Target Price from Brokerages
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has been given an average rating of “Buy” by the thirteen ratings firms that are presently covering the firm, MarketBeat reports. Ten investment analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. The average 12-month […] - 2025-04-23 02:30:49
Bank of New York Mellon Corp Boosts Stock Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
Bank of New York Mellon Corp boosted its holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 5.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 200,121 shares of the company’s stock after buying an additional 10,338 shares during the quarter. […] - 2025-03-24 05:08:53
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives $26.33 Consensus Price Target from Brokerages
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has received a consensus rating of “Buy” from the thirteen ratings firms that are covering the company, Marketbeat Ratings reports. Ten investment analysts have rated the stock with a buy recommendation and three have assigned a strong buy recommendation to the company. The average twelve-month target […] - 2025-03-04 04:22:57
Warren Buffett's State of the Market
In this podcast, Motley Fool analyst Tim Beyers and host Dylan Lewis discuss: - 2025-03-03 14:29:00
Analysts Set Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) PT at $26.33
Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) have received a consensus recommendation of “Buy” from the thirteen research firms that are currently covering the stock, MarketBeat reports. Ten investment analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. The average […] - 2025-02-07 04:32:50
China Universal Asset Management Co. Ltd. Buys Shares of 15,549 Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
China Universal Asset Management Co. Ltd. bought a new stake in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) in the fourth quarter, Holdings Channel reports. The fund bought 15,549 shares of the company’s stock, valued at approximately $108,000. A number of other hedge funds have also made changes to their positions in […] - 2025-02-04 07:46:56

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) MNMD holdings

DateNumber of MNMD Shares HeldBase Market Value of MNMD SharesLocal Market Value of MNMD SharesChange in MNMD Shares HeldChange in MNMD Base ValueCurrent Price per MNMD Share HeldPrevious Price per MNMD Share Held
2025-12-03 (Wednesday)53,916USD 643,757MNMD holding decreased by -6470USD 643,7570USD -6,470 USD 11.94 USD 12.06
2025-12-02 (Tuesday)53,916MNMD holding increased by 1935USD 650,227MNMD holding increased by 12940USD 650,2271,935USD 12,940 USD 12.06 USD 12.26
2025-12-01 (Monday)51,981USD 637,287MNMD holding decreased by -20273USD 637,2870USD -20,273 USD 12.26 USD 12.65
2025-11-28 (Friday)51,981MNMD holding increased by 130USD 657,560MNMD holding increased by 30163USD 657,560130USD 30,163 USD 12.65 USD 12.1
2025-11-27 (Thursday)51,851USD 627,397USD 627,3970USD 0 USD 12.1 USD 12.1
2025-11-26 (Wednesday)51,851MNMD holding increased by 390USD 627,397MNMD holding increased by 16040USD 627,397390USD 16,040 USD 12.1 USD 11.88
2025-11-25 (Tuesday)51,461MNMD holding increased by 650USD 611,357MNMD holding increased by 14328USD 611,357650USD 14,328 USD 11.88 USD 11.75
2025-11-24 (Monday)50,811MNMD holding increased by 130USD 597,029MNMD holding increased by 55756USD 597,029130USD 55,756 USD 11.75 USD 10.68
2025-11-21 (Friday)50,681USD 541,273MNMD holding decreased by -10136USD 541,2730USD -10,136 USD 10.68 USD 10.88
2025-11-20 (Thursday)50,681MNMD holding decreased by -516USD 551,409MNMD holding decreased by -8174USD 551,409-516USD -8,174 USD 10.88 USD 10.93
2025-11-19 (Wednesday)51,197MNMD holding increased by 129USD 559,583MNMD holding decreased by -23103USD 559,583129USD -23,103 USD 10.93 USD 11.41
2025-11-18 (Tuesday)51,068MNMD holding increased by 774USD 582,686MNMD holding increased by 12352USD 582,686774USD 12,352 USD 11.41 USD 11.34
2025-11-17 (Monday)50,294MNMD holding increased by 258USD 570,334MNMD holding increased by 2425USD 570,334258USD 2,425 USD 11.34 USD 11.35
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MNMD by Blackrock for IE00BDZVHG35

Show aggregate share trades of MNMD

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-02BUY1,93512.75012.040 12.111USD 23,435 8.30
2025-11-28BUY13012.80012.190 12.251USD 1,593 8.24
2025-11-26BUY39012.34011.690 11.755USD 4,584 8.20
2025-11-26BUY39012.34011.690 11.755USD 4,584 8.20
2025-11-25BUY65012.08011.640 11.684USD 7,595 8.17
2025-11-24BUY13011.87010.532 10.666USD 1,387 8.15
2025-11-20SELL-51611.82010.858 10.954USD -5,652 8.12 Loss of -1,462 on sale
2025-11-19BUY129 10.930* 8.10
2025-11-18BUY77411.60010.820 10.898USD 8,435 8.08
2025-11-17BUY25811.57111.170 11.210USD 2,892 8.06
2025-11-14BUY12911.87011.080 11.159USD 1,440 8.04
2025-11-12BUY12913.14012.110 12.213USD 1,575 7.99
2025-11-10BUY12812.89011.665 11.788USD 1,509 7.93
2025-11-06BUY12811.70011.130 11.187USD 1,432 7.89
2025-11-04BUY12912.53011.880 11.945USD 1,541 7.83
2025-10-30BUY64513.50012.600 12.690USD 8,185 7.72
2025-10-29BUY25812.91013.740 13.657USD 3,524 7.68
2025-10-22SELL-51212.43012.630 12.610USD -6,456 7.50 Loss of -2,614 on sale
2025-10-20BUY25613.16014.300 14.186USD 3,632 7.43
2025-10-17BUY63913.65013.860 13.839USD 8,843 7.38
2025-10-15BUY1,01612.66013.055 13.016USD 13,224 7.34
2025-10-03BUY90312.56012.760 12.740USD 11,504 7.26
2025-10-02BUY12912.22012.452 12.429USD 1,603 7.22
2025-09-30BUY25811.79012.000 11.979USD 3,091 7.15
2025-09-26BUY25810.67010.760 10.751USD 2,774 7.08
2025-09-25BUY2589.77010.300 10.247USD 2,644 7.06
2025-09-18BUY1319.4809.810 9.777USD 1,281 7.04
2025-09-17BUY3939.57010.040 9.993USD 3,927 7.02
2025-07-17SELL-2588.8808.880 8.880USD -2,291 6.94 Loss of -500 on sale
2025-07-11SELL-1,0408.0608.170 8.159USD -8,485 6.90 Loss of -1,313 on sale
2025-07-02BUY7,1507.0807.200 7.188USD 51,394 6.87
2025-06-25BUY2586.8407.190 7.155USD 1,846 6.88
2025-06-11BUY2627.4008.050 7.985USD 2,092 6.86
2025-06-10BUY2627.8908.195 8.164USD 2,139 6.85
2025-06-04SELL-1317.6507.920 7.893USD -1,034 6.82 Loss of -141 on sale
2025-04-23BUY1316.1106.330 6.308USD 826 6.84
2025-04-10SELL-1,0405.1405.511 5.474USD -5,693 7.05 Profit of 1,636 on sale
2025-04-08SELL-1304.8905.750 5.664USD -736 7.11 Profit of 189 on sale
2025-04-07SELL-1315.4305.550 5.538USD -725 7.15 Profit of 211 on sale
2025-04-04SELL-6605.4305.550 5.538USD -3,655 7.18 Profit of 1,085 on sale
2025-04-01BUY5325.5405.835 5.806USD 3,089 7.24
2025-03-31SELL-3965.8506.065 6.044USD -2,393 7.27 Profit of 486 on sale
2025-03-21BUY3,8006.7206.825 6.814USD 25,895 7.37
2025-03-14SELL-1,9206.3506.650 6.620USD -12,710 7.49 Profit of 1,663 on sale
2025-03-07SELL-2406.8306.910 6.902USD -1,656 7.65 Profit of 180 on sale
2025-03-04SELL-1206.2306.265 6.261USD -751 7.79 Profit of 183 on sale
2025-02-25BUY2406.7507.140 7.101USD 1,704 8.04
2025-02-19SELL-1188.2808.600 8.568USD -1,011 8.09 Loss of -56 on sale
2025-02-13BUY3548.6509.180 9.127USD 3,231 7.79
2025-02-12BUY1188.5108.671 8.655USD 1,021 7.73
2025-02-11BUY4728.2358.490 8.464USD 3,995 7.70
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MNMD

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19171,9770548,60131.3%
2025-09-18126,48340486,34026.0%
2025-09-17138,6901,410577,58624.0%
2025-09-16170,0470470,27936.2%
2025-09-15120,4140343,27335.1%
2025-09-12174,826500476,12836.7%
2025-09-11140,155772292,77947.9%
2025-09-10160,3837,052504,89331.8%
2025-09-09143,76619349,63541.1%
2025-09-08138,31842402,04734.4%
2025-09-05134,6018,324506,11226.6%
2025-09-04164,4740500,47132.9%
2025-09-03103,599481310,67033.3%
2025-09-02131,82633,495453,06829.1%
2025-08-29345,36751,132968,65935.7%
2025-08-28267,2715,682826,61332.3%
2025-08-2783,4301,100324,40325.7%
2025-08-2681,446939409,51319.9%
2025-08-25284,8885,3251,326,25721.5%
2025-08-22105,061675716,83114.7%
2025-08-2184,96010358,23923.7%
2025-08-20113,335877343,17933.0%
2025-08-1970,993985270,94626.2%
2025-08-18124,552410448,22027.8%
2025-08-1598,9591,329301,29232.8%
2025-08-14117,1612,144408,79028.7%
2025-08-13231,9823,631500,30446.4%
2025-08-12171,6162,072823,12320.8%
2025-08-11196,9381,675627,06031.4%
2025-08-08184,676325550,18733.6%
2025-08-07152,82260382,20340.0%
2025-08-06143,7111,477342,46542.0%
2025-08-05191,818446555,36434.5%
2025-08-04182,42735,147570,38432.0%
2025-08-01262,34927,304675,78638.8%
2025-07-31194,217456523,83737.1%
2025-07-30128,0628,953329,45838.9%
2025-07-29353,5081,661950,20737.2%
2025-07-28156,156120342,66145.6%
2025-07-25113,2772,780611,92418.5%
2025-07-24129,8302,868511,43725.4%
2025-07-23121,6211,561435,69327.9%
2025-07-22171,6932,099575,62629.8%
2025-07-21588,1577,6371,659,75235.4%
2025-07-18235,5893,310586,92140.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.


Copyright Market Footprint Ltd. Privacy Policy